ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Clinical trial NCT05116683 · TERMINATED

Trial details

NCT number: NCT05116683
Sponsor: Benjamin Izar
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leiomyosarcoma Liposarcoma

Start date: 2022-01-11
Primary completion: 2022-10-27
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.